Literature DB >> 18049031

Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.

Shuntaro Kagiyama1, Kiyoshi Matsumura, Masayo Fukuhara, Kanae Sakagami, Koji Fujii, Mitsuo Iida.   

Abstract

Aldosterone infusion with high salt treatment induces cardiac fibrosis in rats. Aldosterone enhanced angiotensin II (Ang II) has been shown to induce proliferation and increase the expression of Ang II receptor mRNA and Ang II binding in vitro. To investigate the role of Ang II type 1a receptor (AT1aR) in aldosterone-and-salt (Ald-NaCl)-induced cardiac fibrosis, we subcutaneously infused aldosterone (0.15 microg/h) and 1% NaCl (Ald-NaCl) into AT1aR knockout mice (AT1aR-KO) or wild type mice (Wt). To examine the role of NaCl on cardiac fibrosis, we gave some of the aldosterone-treated AT1aR-KO tap water (Ald-H2O). Ald-NaCl treatment increased systolic blood pressure and induced cardiac hypertrophy in both strains, whereas there were no such changes in the mice without aldosterone. Severe cardiac fibrosis was seen in Ald-NaCl-treated AT1aR-KO and not in Ald-NaCl-treated Wt. In contrast, Ald-NaCl-treated Wt with co-administration of an active metabolite of olmesartan, the AT1aR antagonist (10 mg/kg/day) did not show cardiac fibrosis. Na+/H+ exchanger, and Na+-K+ ATPase alpha2 subunit mRNA were decreased in AT1aR-KO. Na+/Ca2) exchanger mRNA was lower in AT1aR-KO than Wt and was decreased by Ald-NaCl in both strains. Phosphorylation of epidermal growth factor receptor and extracellular signal-regulated kinase was increased by Ald-NaCl treatment in AT1aR-KO. Connective tissue growth factor (CTGF) and osteopontin mRNA were increased and accumulation of CTGF proteins was seen in the hearts of Ald-NaCl-treated AT1aR-KO. Ald-H2O-treated AT1aR-KO did not show any cardiac fibrosis. These results suggest that Ald-NaCl-induced cardiac fibrosis required both aldosterone and salt. Because cardiac fibrosis was exaggerated in Ald-NaCl-treated AT1aR-KO but was not seen in Wt treated with Ald-NaCl and olmesartan, AT1aR may not play a primary role in progression of cardiac fibrosis by Ald-NaCl, and gene disruption of AT1aR may have some implications in this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049031     DOI: 10.1291/hypres.30.979

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

Review 1.  Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.

Authors:  Hiroyuki Konya; Masayuki Miuchi; Kahori Satani; Satoshi Matsutani; Taku Tsunoda; Yuzo Yano; Tomoyuki Katsuno; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  World J Diabetes       Date:  2014-10-15

2.  Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors.

Authors:  Marie Briet; Tlili Barhoumi; Muhammad Oneeb Rehman Mian; Suellen C Coelho; Sofiane Ouerd; Yohann Rautureau; Thomas M Coffman; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2016-04-04       Impact factor: 10.190

3.  Dietary NaCl affects bleomycin-induced lung fibrosis in mice.

Authors:  Wensheng Chen; Darrell Pilling; Richard H Gomer
Journal:  Exp Lung Res       Date:  2017-12-08       Impact factor: 2.459

4.  NaCl potentiates human fibrocyte differentiation.

Authors:  Nehemiah Cox; Darrell Pilling; Richard H Gomer
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

5.  Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor.

Authors:  Eric E Essick; Flora Sam
Journal:  Int J Hypertens       Date:  2011-05-22       Impact factor: 2.420

6.  Moderate inappropriately high aldosterone/NaCl constellation in mice: cardiovascular effects and the role of cardiovascular epidermal growth factor receptor.

Authors:  Barbara Schreier; Sindy Rabe; Sabrina Winter; Stefanie Ruhs; Sigrid Mildenberger; Bettina Schneider; Maria Sibilia; Michael Gotthardt; Sabine Kempe; Karsten Mäder; Claudia Grossmann; Michael Gekle
Journal:  Sci Rep       Date:  2014-12-11       Impact factor: 4.379

7.  Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.

Authors:  Hiroshi Kusunoki; Yoshiaki Taniyama; Hiromi Rakugi; Ryuichi Morishita
Journal:  J Am Heart Assoc       Date:  2013-04-22       Impact factor: 5.501

8.  FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.

Authors:  Ineke Böckmann; Jonas Lischka; Beatrice Richter; Jennifer Deppe; Anja Rahn; Dagmar-Christiane Fischer; Jörg Heineke; Dieter Haffner; Maren Leifheit-Nestler
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.